Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Wednesday, 3 November 2021, 15:00 HKT/SGT
Share:
    

Source: Medikhana Co. Pte. Ltd.
Medikhana's IEO is officially live on GokuMarket

SINGAPORE, Nov 3, 2021 - (ACN Newswire) - MedikahanaX (MKX) just announced that its IEO is officially live on GokuMarket's IEO Launchpad. Typically, this is a prime opportunity for investors to participate in the life-changing project.

As much as many industries are moving to blockchain to solve their current problems, the agricultural sector has mostly been forgotten. MedikhanaX is bridging this gap by using blockchain to ensure agricultural industries access quality assurance, sales tracking, and technical cultivation support to farmers who grow cannabis, Kratom, vegetables, and fruits. In addition to that, MedikhanaX supports those who want to do cannabis-related businesses in South East Asia to get licenses. It supports the growing, distributing, and selling of cannabis-related products.

MedikhanaX uses the Japanese Agricultural IoT system to ensure the Japanese quality is maintained. The Japanese are well-known for exceeding international standards when it comes to facilities, equipment, and technology. As a result of this, Medikhana supported products are of premium quality.

The company has tapped into the explosive CBD industry, which is growing by the day as more people discover the advantages of CBD products. Using a blockchain model ensures transparency. Through blockchain, there is traceability from cultivation, manufacturing, distribution, and sales. This, as a result, helps consumers track and confirm the quality and safety of their products. Blockchain also helps to filter out unethical operators in the market.

Combining blockchain, IoT, and other AgriTech technologies ensures CBD production is secure, transparent, and efficient. It also drives quick partnerships with interested parties and faster growth of the company's value.

Medikhana has a partner company, Siam Reiwa (2020) Co., Ltd. or Reiwa in Buriram, that manufactures and sells CBD products. Reiwa is the first Japanese-based company in South East Asia to acquire a Hemp license. Reiwa company will act as an anchor that may drive the development of a Cannabis industrial park in the future.

Medikhana is strategically located in Singapore, an international market hub with a thriving business and regulatory environment. Its production location is in Thailand, which is also ideal for climate, business, and regulation. As an additional strategy, Medikhana does technical exchanges with companies in Israel, the hub for medical cannabis, to ensure it produces high-quality cannabis and CBD products. Medikhana complies with the SOPs (Standard Operating Procedures) for total quality control (TQC). For exemplary performance, the company has accomplished managers and advisors onboard.

The GokuMarket exchange platform has many advantages as compared to others as users can participate in the fundraising using both cryptocurrencies, and debit and credit cards. To participate in the IEO, users will be able to purchase MedikhanaX tokens (MKX), which they can directly buy on the GokuMarket Launchpad. The best part is that all early birds can buy the MKX tokens at a discounted price. Once a user buys MKX, they can stake them to earn up to 15% annual yield on the staking amount. All the rewards they get are daily directly credited into their wallet.

Medikhana is working on launching its own decentralized finance platform in Q1 of 2022. MKX holders at the time will be able to trade on the platform.

About MedikhanaX

Medikhana, rebranded to MedikhanaX, is a Singaporean-based company using blockchain to ensure agricultural industries can access quality assurance, sales tracking, and technical cultivation support to farmers who grow cannabis, Kratom, vegetables, and fruits. In addition to that, MedikhanaX supports those who want to do cannabis-related businesses in South East Asia to get licenses. It supports the growing, distributing, and selling of cannabis-related products.

Social Links
Twitter: https://twitter.com/MedikhanaX
Medium: https://medium.com/@MedikhanaX
Telegram: https://t.me/medikhana
YouTube: https://bit.ly/3lct5JB

Media contacts
Company: Medikhana Co. Pte. Ltd.
Contact: Koji Fujishiro
Address: 10 Eunos Road 8, #13-06, Singapore Post Centre, Singapore 408600
E-mail: contact@medikhana.com
Website: https://medikhana.com/

SOURCE: Medikhana Co. Pte. Ltd.


Topic: Press release summary
Source: Medikhana Co. Pte. Ltd.


http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2022 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.



Latest Press Releases
Pixis (Formerly Pyxis One) Raises $100M in SoftBank Vision Fund 2-led Series C to Grow Its Codeless AI Infrastructure   
Jan 22, 2022 02:00 HKT/SGT
2022's First SPAC and Metaverse Investment Opportunities Virtual Investment Conference in Hong Kong  
Jan 21, 2022 19:35 HKT/SGT
Yeahka ranks No. 1 in the non-bank independent QR code payment service market in China  
Jan 21, 2022 17:51 HKT/SGT
Mitsubishi Power Europe and Stockholm Exergi partner to deliver clean power and heat to the city of Stockholm  
Friday, January 21, 2022 3:51:00 PM
MoU Between Verofax Asia and Distichain to Enable Empowered Digital Global Trade  
Jan 21, 2022 14:00 HKT/SGT
What You Need to Know about TRON in 2022  
Jan 21, 2022 13:00 HKT/SGT
Ingerson Capital Partners Releases the Performance Report on 'Asia Driving Demand for Longer Trading Hours'  
Jan 21, 2022 13:00 HKT/SGT
Realbox launches one of world's first blockchain-based real estate tokenization platforms  
Jan 20, 2022 20:00 HKT/SGT
Slime Royale Announces to Receive Strategic Investment and Incubation Support from Appota Group  
Jan 20, 2022 14:00 HKT/SGT
Hitachi Rail Awarded Contract to Operate and Maintain Princess Noura Bint Abdul Rahman University Autonomous System in Riyadh, Saudi Arabia  
Thursday, January 20, 2022 1:14:00 PM
More Press release >>
 Events:
More >>
 News Alerts
Copyright © 2022 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: